Article
Real‐World Data of Comprehensive Cancer Genomic Profiling Tests Performed in the Routine Clinical Setting in Sarcoma
1 Aug 2025
Abstract excerpt
INTRODUCTION: Next-generation sequencing-based comprehensive cancer genomic profiling (CGP) tests are beneficial for refining diagnosis and personalized treatment of various cancers. However, the clinical impact of CGP, as covered by public health insurance in the management of sarcomas, remains unknown. Especially, the data on the utility of the newly emerging dual DNA-RNA panel compared to the conventional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
